A reappraisal of immune-mediated glomerulosclerosis

Kidney International

Volumn 49, Issue 3, 1996, Pages 605-611

  Bergijk, Eline C ^a,b   De Heer, Emile ^a   Hoedemaeker, Philip J ^a   Bruijn, Jan A ^a  

^a L1 Q ^*

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0029974557     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.87     Document Type: Article

References (75)

1. BRUIJN JA, BERGIJK EC, DE HEER E, FLEUREN GJ, HOEDEMAEKER PJ: Induction and progression of experimental lupus nephritis: Exploration of a pathogenetic pathway. (Editorial Review). Kidney Int 41:5-13, 1992
2. VAN LIEW JB, BRENTJENS JR, NOBLE B: Relationship of kidney function to immunopathology in chronic serum sickness of rats. Kidney Int 24:160-169, 1983
3. HOGENDOORN PCW, BRUIJN JA, GELOK EWA, BROEK LJCM, FLEUREN GJ: Development of progressive glomerulosclerosis in experimental chronic serum sickness. Nephrol Dial Transplant 5:100-109, 1990
4. EL NAHAS AM: Growth factors and glomerular sclerosis. Kidney Int 41(Suppl 36):S15-S20, 1992
5. FLOEGE J, JOHNSON RJ: Cytokines in renal inflammation. Curr Opin Nephrol Hypertens 2:449-457, 1993
6. BORDER WA, NOBLE NA: From serum sickness to cytokines: Advances in understanding the molecular pathogenesis of kidney disease. Lab Invest 68:125-128, 1993
7. SEDOR JR, KONIECZKOWSKI M, HUANG S, GRONICH JH, NAKAZATO Y, GORDON G, KING CH: Cytokines, mesangial cell activation and glomerular injury. Kidney Int 43(Suppl 39):S65-S70, 1993
8. Deleted in proof.
9. VARANI J, TAYLOR CG, RISER B, SHUMAKER DK, YEH K-Y, DAME M, GIBBS DF, TODD RF, DUMLER F, BROMBERG J, KILLEN PD: Mesangial cell killing by leukocytes: Role of leukocyte oxidants and proteolytic enzymes. Kidney Int 42:1169-1177, 1992
10. PFEILSCHIFTER J, KUNZ D, MÜHL H: Nitric oxide: An inflammatory mediator of glomerular mesangial cells. Nephron 64:518-525, 1993
11. STERZEL RB, SCHULZE-LOHOFF E, MARX M: Cytokines and mesangial cells. Kidney Int 43(Suppl 39):S26-S31, 1993
12. SEDOR JR, NAKAZATO Y, KONIECZKOWSKI M: Interleukin-1 and the mesangial cell. Kidney Int 41:595-599, 1992
13. HIRANO T: Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 62:S60-S65, 1992
14. BAUD L, FOUQUERAY B, PHILIPPE C, AMRANI A: Tumor necrosis factor alpha and mesangial cells. Kidney Int 41:600-603, 1992
15. UMLAND SP, RAZAC S, NAHREBNE DK, SEYMOUR BW: Effects of in vivo administration of interferon(IFN)-τ, anti-IFN-τ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clin Immunol Immunopathol 63:66-73, 1992
16. FLOEGE J, ENG E, YOUNG BA, JOHNSON RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 43(Suppl 39):S47-S54, 1993
17. COLIGE AC, LAMBERT CA, NUSGENS BV, LAPIÈRE CM: Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases. Biochem J 285:215-221, 1992
18. BORDER WA, NOBLE NA: Cytokines in kidney disease: The role of transforming growth factor-β. Am J Kidney Dis 22:105-113, 1993
19. BRUIJN JA, ROOS A, DE GEUS B, DE HEER E: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123:34-47, 1994
20. IMAI E, ISAKA Y, FUJIWARA Y, KANEDA Y, KAMADA T, UEDA N: Introduction of a foreign gene into the kidney in vivo: Development of glomerulosclerosis by the transfection of genes for PDGF and TGF-β. Contrib Nephrol 107:205-215, 1994
21. ONG ACM, FINE LG: Loss of glomerular function and tubulointerstitial fibrosis: Cause or effect. Kidney Int 45:345-351, 1994
22. YEE J, KUNCIO GS, NEILSON EG: Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 11:361-366, 1991
23. OOMURA A, NAKAMURA T, ARAKAWA M, OOSHIMA A, ISEMURA M: Alterations in the extracellular matrix components in human glomerular diseases. Virchow Arch 415:151-159, 1989
24. FUNABIKI K, HORIKOSHI S, TOMINO Y, NAGAI Y, KOIDE H: Immunohistochemical analysis of extracellular components in the glomerular sclerosis of patients with glomerulonephritis. Clin Nephrol 34:239-246, 1990
25. KIM Y, BUTKOWSKI R, BURKE B, KLEPPEL MM, CROSSON J, KATZ A, MICHAEL AF: Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 139:1381-1388, 1991
26. ZIYADEH FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
27. BÜYÜKBABANI N, DROZ D: Distribution of the extracellular matrix components in human glomerular lesions. J Pathol 172:199-207, 1994
28. MATSUO S, BRENTJENS JR, ANDRES G, FOIDART JM, MARTIN GR: Distribution of basement membrane antigens in glomeruli of mice with autoimmune glomerulonephritis. Am J Pathol 122:36-49, 1986
29. JONES CL, BUCH B, POST M, MCCULLOGH L, EDDY AA: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141:1381-1396, 1992
30. DOI T, STRIKER LJ, KIMATA K, PETEN EP, YAMADA Y, STRIKER GE: Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287-1290, 1991
31. FLOEGE J, JOHNSON RJ, GORDON K, YOSHIMURA A, CAMPBELL C, IRUELA-ARISPE L, ALPERS CE, COUSER WG: Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int 42:573-585, 1992
32. BERGIJK EC, MUNAUT C, BAELDE JJ, PRINS F, FOIDART F, HOEDEMAEKER PJ, BRUIJN JA: A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol 140:1147-1156, 1992
33. BERGIJK EC, BAELDE HJ, DE HEER E, KILLEN PD, BRUIJN JA: Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness. Exp Nephrol 3:338-347, 1995
34. STRIKER LJ: Modern renal biopsy interpretation: Can we predict glomerulosclerosis? Semin Nephrol 13:508-515, 1993
35. NAKAMURA T, EBIHARA I, SHIRATO I, TOMINO Y, KOIDE H: Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/W F1 mice. Am J Pathol 139:437-450, 1991
36. MUNAUT C, BERGIJK EC, BAELDE JJ, NOËL A, FOIDART JM, BRUIJN JA: A molecular biologic study of extracellular matrix components during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Lab Invest 67:580-587, 1992
37. DAVIES M, MARTIN J, THOMAS GJ, LOVETT DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
38. LOVETT DH, JOHNSON RJ, MARTI HP, MARTIN J, DAVIES M, COUSER WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98, 1992
39. TANG WW, FENG L, XIA Y, PETERS J, WILSON CB: Expression of embryonic fibronectins due to alternative splicing after immune renal injury. (abstract) J Am Soc Nephrol 4:667, 1993
40. BERGIJK EC, KOOTSTRA CJ, BAELDE JJ, DE HEER E, KILLEN PD, BRUIJN JA: Cloning of the mouse fibronectin V-region and variation of its splicing pattern in experimental immunecomplex glomerulonephritis. J Pathol (in press)
41. BERGIJK EC, BAELDE JJ, DE HEER E, KILLEN PD, BRUIJN JA: Differential expression of collagen type IV subchains in experimental glomerulosclerosis. (abstract) J Am Soc Nephrol 5:801, 1995
42. SCHIEREN G, FUNABIKI K, KILLEN PD: Regulation of the murine α5(IV) collagen gene differs from the major collagen IV chains in NIH3T3 cells. (abstract) Kidney Int 47:698, 1995
43. KIM Y, KLEPPEL MM, BUTKOWSKI R, MAUER SM, WIESLANDER J, MICHAEL AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
44. KOOTSTRA CJ, BERGIJK EC, VENINGA A, DE HEER E, ABRAHAMSON DR, BRUIJN JA: Qualitative alterations of laminin expression in experimental lupus nephritis. Am J Pathol 147:476-488, 1995
45. ABRASS CK, SPICER D, RAUGI GJ: Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture. Kidney Int 46:613-620, 1994
46. BERGIJK EC, BAELDE JJ, DE HEER E, KILLEN PD, BRUIJN JA: Specific accumulation of exogenous fibronectin in experimental glomerulosclerosis. J Pathol 176:191-199, 1995
47. BERGIJK EC, BAELDE JJ, DE HEER E, BRUIJN JA: Prevention of glomerulosclerosis by early cyclosporin treatment of experimental lupus nephritis. Kidney Int 46:1663-1673, 1994
48. WIGGINS R, GOYAL M, MERRITT S, KILLEN PD: Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. Lab Invest 68:557-565, 1993
49. HOLDSWORTH SR, THOMSON NM, GLASGOW F, ATKINS RC: The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: Studies using glomerular culture and electron microscopy. Clin Exp Immunol 37:38-43, 1979
50. TSUMAGARI T, TANAKA K: Effects of fibrinogen degradation products on glomerular mesangial cells in culture. Kidney Int 26:712-718, 1984
51. RUOSLAHTI E, NOBLE NA, KAGAMI S, BORDER W: Integrins. Kidney Int 45(Suppl 44):S17-S22, 1994
52. ADLER S: Integrin matrix receptors in renal injury. Kidney Int 45(Suppl 44):S86-S89, 1994
53. BRUIJN JA, DINKLO NJCM: Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 69:329-335, 1993
54. WAYNER EA, GARCIA-PADO A, HUMPHRIES MJ, MCDONALD JA, CARTER WG: Identification and characterization of the lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 109:1321-1330, 1989
55. ROY-CHAUDHURY P, WILLIAMS J, KHONG TF, WU B, MACLEOD AM, DUTHIE LA, SIMPSON JG, POWER DA: CD44 is expressed by cultured mesangial cells and in the proliferative phase of the Thy 1 model. (abstract) J Am Soc Nephrol 4:630, 1993
56. SALVARREY M, ROSTAGNO A: Affinity of fibronectin for polyclonal IgG. Clin Exp Immunol 76:92-96, 1989
57. RUOSLAHTI R: Fibronectin and its receptors. Annu Rev Biochem 57:375-413, 1988
58. ENGVALL E, RUOSLAHTI E: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20:1-10, 1977
59. WILSON CL, SCHWARZBAUER JE: The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots. J Cell Biol 119:923-933, 1992
60. KAWASAKI K, YAOITA E, YAMAMOTO T, TAMATANI T, MIYASAKA M, KIHARA I: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150:1074-1083, 1993
61. UMLAND SP, RAZAC S, NAHREBNE DK, SEYMOUR BW: Effects of in vivo administration of interferon(IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clin Immunol Immunopathol 63:66-73, 1992
62. KARKAR AM, KOSHONO Y, CASHMAN SJ, DASH AC, BONNEFOY J, MEAGER A, REES AJ: Passive immunization against tumour necrosis factor-alpha and IL-1β protects from LPS enhancing glomerular nephrotoxic nephritis in rats. Clin Exp Immunol 90:312-318, 1992
63. BRENNER BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324-F337, 1985
64. GROND J, WEHNING JJ: Mesangial cell injury, glomerulosclerosis, and therapeutic intervention, in Nutritional and Pharmacological Strategies in Chronic Renal Failure, edited by ALBERTAZZI A, CAPPELLI P, DEL ROSSO G, DI PAOLO B, EVANGELISTA M, PALMIERI PF, Contrib Nephrol, Basel, Karger, 1990, pp 229-239
65. IKEYA M, NAGASE M, HONDA N: Intramolecular distribution of fibronectin in primary glomerular disease. Clin Nephrol 24:53-59, 1985
66. ASSAD L, SCHWARTZ MM, VIRTANEN I, GOULD VE: Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virchow Arch 63:307-316, 1993
67. FLOEGE J, ENG E, YOUNG BA, COUSER WG, JOHNSON RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
68. BRUGGEMAN LA, HORIKOSHI S, BURBELO PD, YAMADA Y, KLOTMAN PE: Physiology and cell biology update: Mechanisms of type IV collagen gene regulation. Am J Kidney Dis XVIII:134-139, 1991
69. FISCHER G, SCHMIDT C, OPITZ J, CULLY Z, KÜHN K, PÖSCHL E: Identification of a novel sequence element in the common promoter region of human collagen type IV genes, involved in the regulation of divergent transcription. Biochem J 292:687-695, 1993
70. PARKER MI, SMITH AA, BOAST S, SU MW, RAMIREZ F: Regulation of the human α2(I) procollagen gene by a trans-acting factor. Ann NY Acad Sci 580:451-453, 1990
71. OKANO R, MITA T, MATSUI T: Characterization of a novel promoter structure and its transcriptional regulation of the murine laminin B1 gene. Biochim Biophys Acta 1132:49-57, 1992
72. NAKAJIMA T, NAKAMURA T, TSUNODA S, NAKADA S, ODA K: E1A-responsive elements for repression of rat fibronectin gene transcription. Mol Cell Biol 12:2837-2846, 1992
73. HUH GS, HYNES RO: Elements regulating an alternatively spliced exon of the rat fibronectin gene. Mol Cell Biol 13:5301-5314, 1993
74. LAVIGUEUR A, LABRANCHE H, KORNBLIHTT AR, CHABOT B: A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Gene Dev 7:2405-2417, 1993
75. KIM S-J, ANGEL P, LAFYATIS R, HATTORI K, KIM KY, SPORN MB, KARIN M, ROBERTS AB: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497, 1990